LOMBARDI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 968
EU - Europa 300
AS - Asia 267
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 1.540
Nazione #
US - Stati Uniti d'America 965
IT - Italia 136
CN - Cina 123
DE - Germania 49
SG - Singapore 36
TR - Turchia 32
ID - Indonesia 24
SE - Svezia 23
UA - Ucraina 22
GB - Regno Unito 16
HK - Hong Kong 11
PL - Polonia 10
IR - Iran 9
CZ - Repubblica Ceca 7
JP - Giappone 7
BE - Belgio 6
FI - Finlandia 6
FR - Francia 6
NO - Norvegia 6
IQ - Iraq 5
KR - Corea 5
PT - Portogallo 4
TW - Taiwan 4
CA - Canada 3
DK - Danimarca 3
IN - India 3
GE - Georgia 2
IL - Israele 2
NG - Nigeria 2
RO - Romania 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
MY - Malesia 1
NL - Olanda 1
PK - Pakistan 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 1.540
Città #
Chandler 177
Fairfield 103
Ashburn 59
Ferrara 53
Woodbridge 50
Houston 43
Ann Arbor 41
Cambridge 36
New York 36
Seattle 35
Princeton 34
Wilmington 34
Shanghai 28
Izmir 27
Milan 26
Jakarta 23
Singapore 22
Beijing 21
Bremen 21
Jacksonville 20
Nanjing 19
Redwood City 13
Dearborn 11
Los Angeles 10
Warsaw 10
Ferrara di Monte Baldo 8
Hebei 8
Bologna 7
San Diego 7
Boardman 6
Brno 6
Brussels 5
Guangzhou 5
Hong Kong 5
Piemonte 5
Baghdad 4
Cagliari 4
Chicago 4
Nanchang 4
Rochester 4
San Mateo 4
Santa Clara 4
Shenyang 4
Copenhagen 3
Helsinki 3
Jiaxing 3
Munich 3
Norwalk 3
Oslo 3
Racale 3
Silveira 3
Taipei 3
Tianjin 3
Toronto 3
Washington 3
Zhengzhou 3
Alexandria 2
Andover 2
Augusta 2
Belvedere Spinello 2
Changsha 2
Cheltenham 2
Clifton 2
Des Moines 2
Dong Ket 2
Duncan 2
Falls Church 2
Florence 2
Hangzhou 2
Henderson 2
Ithaca 2
Jinan 2
Kunming 2
Lagos 2
Leawood 2
London 2
Monmouth Junction 2
Naples 2
Ningbo 2
Ponticelli 2
Reggio Emilia 2
Sabz 2
Semnan 2
Seocho-gu 2
Tabriz 2
Tel Aviv 2
Worcester 2
Balk 1
Bhubaneswar 1
Bloemfontein 1
Boxborough 1
Cento 1
Central District 1
Chengdu 1
Chongqing 1
Dallas 1
Danvers 1
Dongguan 1
Dortmund 1
Emden 1
Totale 1.160
Nome #
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 159
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 122
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 107
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 100
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 74
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 70
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 64
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 60
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 59
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 52
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 51
Exon-Specific U1snRNA-Mediated Rescue of Splicing and Missense Changes in Hemophilia A 50
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 50
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 48
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 47
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 46
Exploring spontaneous readthrough over recurrent F8 nonsense mutations: potential correlation with inhibitor risk? 46
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 43
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 39
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 39
Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein function 39
Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches 38
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 38
Translation termination codons in protein synthesis and disease 31
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 31
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 31
Targeted molecular strategies for X-linked genetic disorders: the paradigmatic models of Fabry disease and Haemophilias 28
Deep molecular mechanisms of F8 exon 19 variants and translational approaches in Hemophilia A 27
Rescue of multiple Haemophilia A-causing mutations by a single ExSpeU1: the importance of the genomic context 22
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 21
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 19
Totale 1.651
Categoria #
all - tutte 9.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 170
Totale 10.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 36 8 13 30 23 27 23 19 20 10 9 5
2020/2021242 7 5 9 14 13 28 31 46 9 21 32 27
2021/2022280 52 34 10 4 20 14 7 7 8 20 19 85
2022/2023372 30 49 10 53 55 38 30 22 52 3 17 13
2023/2024255 9 21 12 4 13 49 9 23 8 15 11 81
2024/202530 30 0 0 0 0 0 0 0 0 0 0 0
Totale 1.651